Education
About Us
Working with TipRanks
Follow Us
Drugs Made In America Acquisition Corp. (DMAA)
NASDAQ:DMAA
Drugs Made In America Acquisition Corp. (DMAA) Ownership Overview
2.39%
Mutual Funds
45.83% Other Institutional Investors
0.29% ETFs
51.50% Public Companies and
Individual Investors
The ownership structure of Drugs Made In America Acquisition Corp. (DMAA) stock is a mix of institutional, retail, and individual investors. Approximately 48.50% of the company’s stock is owned by Institutional Investors, and 51.50% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 900,000 | Institution | 2.69% | 9,103,500 | |
| 800,000 | Institution | 2.39% | 8,092,000 | |
| 70,774 | Institution | 0.21% | 715,879 | |
| 25,000 | Institution | 0.07% | 252,875 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 800,000 | Institution | 2.39% | 8,092,000 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 70,774 | Institution | 0.21% | 714,817 | |
| 25,000 | Institution | 0.07% | 347,787 |
FAQ
Who Owns Drugs Made In America Acquisition Corp. (DMAA)?
Currently, no data Available
What percentage of Drugs Made In America Acquisition Corp. (DMAA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 45.83% of Drugs Made In America Acquisition Corp. (DMAA) stock is held by institutional investors.
What percentage of Drugs Made In America Acquisition Corp. (DMAA) stock is held by retail investors?
According to the latest TipRanks data, approximately 51.50% of Drugs Made In America Acquisition Corp. (DMAA) stock is held by retail investors.
Who owns the most shares of Drugs Made In America Acquisition Corp. (DMAA)?
Robert Henry Lynch owns the most shares of Drugs Made In America Acquisition Corp. (DMAA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.